Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
September 06, 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical CareSeptember 06, 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Key contacts
Lee Harris Partner United Kingdom Antony Walsh Partner United Kingdom Barri Mendelsohn Partner United Kingdom Rachel Cooper Partner United Kingdom Edward M. Tompkin-Haag Partner United Kingdom Kelly Holmes Partner United Kingdom Philip Crosbie Partner United Kingdom Christopher Murray Partner United Kingdom Latest Insights
Latest News
Latest Events
legal updates June 05, 2026 Cyber Resilience Landscape – An Update to Practical Implementation legal updates June 05, 2026 The UK Employment Rights Act: zero hours and low hours contract provisions legal updates June 04, 2026 FS+ Country Updates – May 2026 legal updates June 04, 2026 UK Real Estate Round Up May 2026 client news June 04, 2026 Advising Howden Joinery Group plc on £390m DIY Kitchens acquisition client news June 04, 2026 Next stop, public ownership: Eversheds Sutherland advises DfT on GTR transi... client news June 03, 2026 A blueprint for growth: Eversheds Sutherland supports Leonard Design Group ... firm news June 01, 2026 Eversheds Sutherland strengthens restructuring offering with senior partner... virtual UK employment law training June 09, 2026 1pm - 4pm (BST) Virtual virtual Education Webinar - Occupational Stress : Preventing Suffering, Enhancing W... June 10, 2026 11:00AM - 12:00PM virtual Nordic (Denmark, Finland, Norway and Sweden) employment law training June 16, 2026 12.45pm - 4pm (BST) Virtual virtual Education Webinar - Equality, diversity and inclusion: current developments... June 17, 2026 11:00AM-12:00PM |